Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season-Reference-Cited by-同舟云学术

Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season

Published:2001-06 Issue:6 Volume:107 Page:971-976
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Wilson Duncan R.,Nouri-Aria Kayhan T.,Walker Samantha M.,Pajno Giovanni B.,O’Brien Fiona,Jacobson Mikila R.,Mackay Ian S.,Durham Stephen R.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells;Bentley;J Allergy Clin Immunol,1992

2. Interleukin-5 and the regulation of eosinophil production;Roboz;Curr Opin Hematol,1999

3. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia;Durham;J Immunol,1992

4. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical cortico-steroids;Masuyama;J Allergy Clin Immunol,1998

5. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis;Ying;Am J Respir Cell Mol Biol,1993

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

2. Biomarkers in allergen immunotherapy: Focus on eosinophilic inflammation;Asia Pacific Allergy;2024-03-11

3. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

4. Evaluation of eosinophil-to-lymphocyte ratio before and after immunotherapy in pediatric allergic rhinitis patients;Saudi Journal of Otorhinolaryngology Head and Neck Surgery;2023

5. Which patients with asthma are most likely to benefit from allergen immunotherapy?;Journal of Allergy and Clinical Immunology;2022-03